Aptevo Therapeutics Inc. (APVO)

NASDAQ: APVO · IEX Real-Time Price · USD

0.298

-0.036 (-10.78%)

At close: Jul 2, 2024, 4:00 PM

0.310

+0.012 (3.93%)

After-hours: Jul 2, 2024, 7:59 PM EDT

Aptevo Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-17.41	8.03	-28.46	-17.75	-40.45	Upgrade
Depreciation & Amortization	0.57	0.9	1.14	1.41	2.24	Upgrade
Share-Based Compensation	2.19	1.8	1.64	1.26	1.6	Upgrade
Other Operating Activities	2.92	-31.75	3.99	-14.23	-5.77	Upgrade
Operating Cash Flow	-11.73	-21.02	-21.68	-29.32	-42.38	Upgrade
Capital Expenditures	0	-0.03	-0.71	-0.09	-0.15	Upgrade
Acquisitions	0	0	0	28.12	4.25	Upgrade
Investing Cash Flow	0	-0.03	-0.71	28.03	4.1	Upgrade
Share Issuance / Repurchase	9.48	6.93	11.44	21.26	20.34	Upgrade
Debt Issued / Paid	-3.47	-12.27	-10.55	2.63	-0.14	Upgrade
Other Financing Activities	-0.01	2.72	25.27	-0.01	-0.06	Upgrade
Financing Cash Flow	6	-2.62	26.16	23.87	20.15	Upgrade
Net Cash Flow	-5.73	-23.67	3.77	22.59	-18.14	Upgrade
Free Cash Flow	-11.73	-21.05	-22.39	-29.41	-42.54	Upgrade
Free Cash Flow Margin	-	-676.01%	-182.17%	-682.43%	-	Upgrade
Free Cash Flow Per Share	-42.19	-181.60	-210.17	-381.57	-641.61	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).